SCHEMBL1241894

SCHEMBL1241894

CC(C)[C@H](NC=O)C(=O)O

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.46
ADH1B P00325 1/20 0.43
ADH1C P00326 1/20 0.43
ADH1A P07327 1/20 0.43
SMN1; SMN2 Q16637 3/20 0.37
MMP2 P08253 4/20 0.37
MMP3 P08254 4/20 0.37
MMP13 P45452 4/20 0.37
MMP1 P03956 3/20 0.37
MMP7 P09237 3/20 0.37
MMP9 P14780 3/20 0.37
LMNA P02545 1/20 0.35
GAA P10253 1/20 0.35
HPGD P15428 1/20 0.35
PLA2G2A P14555 1/20 0.35
PLA2G5 P39877 1/20 0.35
TP53 P04637 1/20 0.35
SLC7A5 Q01650 1/20 0.35
KDM4E B2RXH2 1/20 0.34
FPR2 P25090 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1241896 1.00 ALDH1A1 (0.46) ALDH1A1ADH1BADH1CADH1ASMN1; SMN2
SCHEMBL19932771 1.00 ALDH1A1 (0.46) ALDH1A1ADH1BADH1CADH1ASMN1; SMN2
SCHEMBL28215303 0.98 ALDH1A1 (0.44) ALDH1A1ADH1BADH1CADH1ASMN1; SMN2
Hydrochloric Acid SCHEMBL31244435 0.98 ALDH1A1 (0.44) ALDH1A1ADH1BADH1CADH1ASMN1; SMN2
SCHEMBL18823490 0.83 ADH1B (0.42) ALDH1A1ADH1BADH1CADH1ATP53
SCHEMBL18712598 0.83 ADH1B (0.42) ALDH1A1ADH1BADH1CADH1ATP53
SCHEMBL9006398 0.83 ADH1B (0.42) ALDH1A1ADH1BADH1CADH1ATP53
SCHEMBL22166168 0.83 ADH1B (0.42) ALDH1A1ADH1BADH1CADH1ATP53
SCHEMBL17313812 0.83 ADH1B (0.42) ALDH1A1ADH1BADH1CADH1ATP53
SCHEMBL27258601 0.83 ADH1B (0.42) ALDH1A1ADH1BADH1CADH1ATP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 68 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024219365-A1 NONAQUEOUS ELECTROLYTE FOR NONAQUEOUS-ELECTROLYTE CELL, AND NONAQUEOUS-ELECTROLYTE CELL パナソニックIPマネジメント株式会社 2024-10-24 WO claimed
EP-3697501-B1 HAIR TREATMENT COMPOSITION UNILEVER IP HOLDINGS B V (NL) 2023-06-21 EP claimed
CN-111683720-B Hair treatment composition 联合利华知识产权控股有限公司 2023-04-25 CN claimed
CN-113943219-A Method for preparing ketopantoic acid by using dimethyl oxalate 精晶药业股份有限公司 2022-01-18 CN claimed
CN-109021065-A A method of preparing high anti-cancer activity peptide aplysiatoxin Dolastatin10 复旦大学 2018-12-18 CN claimed
CN-122010765-A Asymmetric alpha-amino acid or polypeptide derivative and preparation method and application thereof 中国科学技术大学 2026-05-12 CN disclosed
CN-122012362-A Method for producing L-valine, genetically engineered bacterium and application thereof 天津科技大学 2026-05-12 CN disclosed
EP-4729624-A1 METHOD FOR PREPARING L-VALINE CRYSTALS AND/OR GRANULES USING PH ADJUSTMENT AND PVA ADDITION CJ Cheiljedang Corporation (KR) 2026-04-22 EP disclosed
WO-2024219365-A1 NONAQUEOUS ELECTROLYTE FOR NONAQUEOUS-ELECTROLYTE CELL, AND NONAQUEOUS-ELECTROLYTE CELL パナソニックIPマネジメント株式会社 2024-10-24 WO disclosed
EP-4425181-A1 COMPOSITION FOR DETECTING OR MEASURING ANALYTE Bertis Inc (KR) 2024-09-04 EP disclosed
CN-117949580-A Detection method of N-formyl-L-leucine and application thereof 中山奕安泰医药科技有限公司 2024-04-30 CN disclosed
US-20240011979-A1 COMPOSITION FOR DETECTING OR MEASURING ANALYTES BERTIS INC. (KR) 2024-01-11 US disclosed
EP-1250134-A1 COMPOSITIONS FOR THE PREVENTION OF DIAPER DERMATITIS Mentis Technologies, L.C. (US) 2002-10-23 EP disclosed
US-6464994-B1 Diaper dermatitis preventative medication and a method for making and using same MENTIS TECHNOLOGIES, L.C. 2002-10-15 US disclosed
WO-2001052842-A1 COMPOSITIONS FOR THE PREVENTION OF DIAPER DERMATITIS MENTIS TECHNOLOGIES, L.C. (US) 2001-07-26 WO disclosed
US-5246960-A Used to treat obesity, hyperlipaemia, atherosclerosis and arteriosclerosis HOFFMANN-LA ROCHE INC. (US) 1993-09-21 US disclosed
CN-1068333-A Has hydrazine analog derivative of pharmacologically active and preparation method thereof CIBA GEIGY AG (CH) 1993-01-27 CN disclosed
EP-0185359-B1 OXETANONE F. HOFFMANN-LA ROCHE AG (CH) 1991-12-04 EP disclosed
US-4931463-A PANCREAS LIPASE INHIBITORS HOFFMANN-LA ROCHE INC. (US) 1990-06-05 US disclosed
EP-0185359-A2 Oxetanone F. HOFFMANN-LA ROCHE AG (CH) 1986-06-25 EP disclosed